Izabela
Izabela Bury S. Pires, Allschwil CH
Patent application number | Description | Published |
---|---|---|
20140192305 | PHOTOREACTIVE COMPOUNDS - The present invention relates to photoreactive compounds that are particularly useful in materials for the alignment of liquid crystals. | 07-10-2014 |
Izabela Chabowska, Gdansk PL
Patent application number | Description | Published |
---|---|---|
20150291648 | N-SUBSTITUTED SECOND GENERATION DERIVATIVES OF ANTIFUNGAL ANTIBIOTIC AMPHOTERICIN B AND METHODS OF THEIR PREPARATION AND APPLICATION - The invention provides semisynthetic N-substituted derivatives of the antifungal antibiotic Amphotericin B and water soluble salts and complexes, pharmaceutical compositions and plant and building treatment products comprising the derivatives and their use as antifungal antibiotics. | 10-15-2015 |
Izabela Dabek, Poznan PL
Patent application number | Description | Published |
---|---|---|
20120157703 | SYNTHESIS OF FLUOROSILICONES AND THEIR DERIVATIVES - The subject of invention is the method of synthesis of fluorosilicone co-polymers of arbitrary topology and general formula 1 in which among others if A stands for CH—O(CH | 06-21-2012 |
20120165565 | SYNTHESIS OF FLUOROCARBOFUNCTIONAL ALKOXYSILANES AND CHLOROSILANES - The subject of invention is the method of synthesis of fluorocarbofunctional alkoxysilanes and chlorosilanes of the general formula HCF | 06-28-2012 |
Izabela Fokt, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20100022466 | THERMALLY-TARGETED DELIVERY OF MEDICAMENTS INCLUDING DOXORUBICIN - Elastin-like polypeptide (ELP) serves as a vector for thermally-targeted delivery of therapeutics, including cytotoxic chemotherapeutic drugs such as doxorubicin. Examples of an ELP-based delivery vehicle can comprise: (1) a cell penetrating peptide, such as a Tat protein, (2) ELP, and (3) the lysosomally degradable glycylphenylalanylleucylglycine (GFLG) spacer and a cysteine residue conjugated to therapeutic such as doxorubicin, or a analog thereof. | 01-28-2010 |
20100130434 | Hexose Compounds to Treat Cancer - Methods of treating glioblastoma and pancreatic cancer are provided by the administration of a therapeutically effective amount of a hexose compound to a subject in need thereof The subject invention includes methods of treating brain and pancreatic cancer comprising the administration of a therapeutically effective amount of a mannose compound to a subject in need thereof The subject invention further includes methods of treating the proliferation of tumors comprising the administration of a therapeutically effective amount of 2-FM to a subject in need thereof. | 05-27-2010 |
20100144802 | Small Molecule Inhibitors for Immune Modulation - Methods of treating immunosuppression by administering a therapeutic amount of a tryphostin compound of the formula: | 06-10-2010 |
20100152121 | Iodo-Hexose Compounds Useful to Treat Cancer - Methods of treating glioblastoma and pancreatic cancer are provided by the administration of a therapeutically effective amount of a iodo-hexose compound to a subject in need thereof. The subject disclosure includes methods of treating glioblastoma and pancreatic cancer comprising the administration of a therapeutically effective amount of a 2-deoxy-2-iodo-D-hexose compound including 2-deoxy-2-iodo-D-mannose, 2-deoxy-2-iodo-D-glucose, 2-deoxy-2-iodo-D-galactose, and/or 2-deoxy-2-iodo-D-talose to a subject in need thereof. | 06-17-2010 |
20110003758 | Inhibitors of Glycolysis Useful In the Treatment of Brain Tumors - Provided herein are methods of treating brain tumors by administering a therapeutically effective amount of a compound of the Formulas I or II to a patient in need thereof. | 01-06-2011 |
20110021805 | COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES - The present invention concerns compounds and their use to treat cell proliferative diseases such as cancer. Compounds of the present invention display significant potency as kinase inhibitors, cause the downregulation of c-myc, and inhibit the growth and survival of cancerous cell lines. | 01-27-2011 |
20110053992 | Novel Inhibitors of Proliferation and Activation of Signal Transducer and Activator of Transcription (STATS) - Pyridine compounds effective in modulation STAT3 and/or STAT5 activation are provided that are useful in the prevention and treatment of proliferative disease and conditions including cancer, inflammation and proliferative skin disorders. | 03-03-2011 |
20110160151 | Novel Acetates of 2-Deoxy Monosaccharides with Anticancer Activity - Novel compounds and methods of using the same to inhibit glycolysis and treat cancer and other diseases are provided herein. | 06-30-2011 |
20120149738 | NOVEL INHIBITORS OF PROLIFERATION AND ACTIVATION OF SIGNAL TRANSDUCER AND ACTIVATORS OF TRANSCRIPTION (STATS) - Pyridine compounds effective in modulation STAT3 and/or STAT5 activation are provided that are useful in the prevention and treatment of proliferative disease and conditions including cancer, inflammation and proliferative skin disorders. | 06-14-2012 |
20120214850 | COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES - The present invention concerns compounds and their use to treat cell proliferative diseases such as cancer. Compounds of the present invention display significant potency as kinase inhibitors, cause the downregulation of c-myc, and inhibit the growth and survival of cancerous cell lines. | 08-23-2012 |
20130129675 | INTERFERON THERAPIES IN COMBINATION WITH BLOCKADE OF STAT3 ACTIVATION - Methods of modulating the INF-induced STAT3 activation in a patient in need-thereof are provided for the treatment of disease. The methods comprise the step of administrating to a patient the combination of a therapeutically effective amount of interferon including INF-α and/or INF-β in combination with a STAT3 inhibitor. | 05-23-2013 |
20140329901 | COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES - The present invention concerns compounds and their use to treat cell proliferative diseases such as cancer. Compounds of the present invention display significant potency as kinase inhibitors, cause the downregulation of c-myc, and inhibit the growth and survival of cancerous cell lines. | 11-06-2014 |
20150094343 | ORALLY BIOAVAILABLE CAFFEIC ACID RELATED ANTICANCER DRUGS - The present invention concerns compounds and their use to treat cell proliferative diseases such as cancer. Compounds of the present invention display significant potency as inhibitors of Jak2/STAT3 pathways and downstream targets and inhibit the growth and survival of cancerous cell lines. | 04-02-2015 |
Izabela Galeska, Pennington, NJ US
Patent application number | Description | Published |
---|---|---|
20080306138 | STABLE NON-AQUEOUS POUR-ON COMPOSITIONS - The present invention relates to a stable, antiparasitic, non-aqueous pour-on parasiticidal composition which comprises an effective amount of amitraz, optionally a macrocyclic lactone, a stabilizer and a carrier system having no active hydroxyl group. | 12-11-2008 |
Izabela Galeska, Newtown, PA US
Patent application number | Description | Published |
---|---|---|
20130203692 | PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF - This invention relates to oral veterinary compositions for combating ectoparasites and endoparasites in animals, comprising at least one systemically-acting active agent in combination with a pharmaceutically acceptable carrier. This invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof. | 08-08-2013 |
20140271526 | ANTIMICROBIAL POLYAMIDE COMPOSITIONS AND MASTITIS TREATMENT - The present invention relates to veterinary compositions and methods of treating and/or preventing mastitis in non-human mammals. More particularly, the present invention relates to the treatment of mastitis in cows. The veterinary composition comprises a water soluble, locally-acting, antimicrobial amine functional polyamide polymer. | 09-18-2014 |
Izabela Goc-Maciejewska, Skorzewo PL
Patent application number | Description | Published |
---|---|---|
20120279426 | CARBOXYLATED-CARBOXYLIC POLYGLYCEROL COMPOSITIONS FOR USE IN CEMENTITIOUS COMPOSITIONS - The invention relates to compositions and methods for modifying cementitious materials such as by reducing setting time. Polymer compositions of the invention are derived by polyetherifying mono-glycerols, optionally with alkylene glycols, to obtain polyglycerol homopolymers or copolymers, and then carboxylating the obtained polyglycerol homopolymers and/or copolymers with an organic acid having at least two carboxylic functionalities. The set retardation effect of the carboxylated-carboxylic polyglycerol polymer compositions in cementitious materials is reduced is compared to polyglycerol polymer not having the carboxylated-carboxylic groups, while its water reducing ability is maintained without loss of early compressive strength. Cementitious compositions and methods involving the carboxylated-carboxylic polyglycerol are also covered by the invention. | 11-08-2012 |
Izabela Grasland, Breteil FR
Patent application number | Description | Published |
---|---|---|
20080288438 | Device and Method for Multimedia Data Retrieval - The invention concerns a device for multimedia data retrieval, said multimedia data being associated with an active component, said device being characterized in that, depending on an external event, some of the active components trigger an action that make the user aware of the multimedia data associated with said active components. | 11-20-2008 |
20100135288 | AUTOMATIC COMPENSATION OF A DELAY OF A SYNCHRONIZATION SIGNAL IN A PACKET SWITCHING NETWORK - The present invention relates to a sending device able to send packets in a network comprising at least two stations, the said device comprising means for extracting image pips on the basis of a synchronization signal, initializing an image counter on the basis of the image pips, initializing a counter every “m” zero-crossings of the image counter, the counter being regulated by a clock produced by the image counter, sampling the counter every period T | 06-03-2010 |
Izabela Janowska, Strasbourg FR
Patent application number | Description | Published |
---|---|---|
20110262312 | PHOTOCATALYSTS BASED ON STRUCTURED THREE-DIMENSIONAL CARBIDE, IN PARTICULAR B-SIC, FOAMS - The invention relates to a photocatalyst comprising a β-SiC cellular foam and a photocatalytically active phase, deposited directly on said cellular foam or on an intermediate phase deposited on said cellular foam. The average size of the cells is between 2500 μm and 5000 μm. The foam can comprise nanotubes or nanofibers (particularly of carbon, SiC, and TiO | 10-27-2011 |
20120241690 | PREPARATION OF GRAPHENE BY MECHANICALLY THINNING GRAPHITE MATERIALS - The preparation of graphene, mono-, bi- and multi-layers from graphite-based precursor materials, for example, pencil lead or graphite, by a method of mechanical thinning on the surface of a planar substrate with controlled roughness, followed by sonication in order to collect the graphene deposited on the substrate in a liquid medium. The bearing force during thinning by mechanical friction enables the number of graphene sheets deposited on the surface of the substrate to be controlled. | 09-27-2012 |
Izabela Koscielny, West Bloomfield, MI US
Patent application number | Description | Published |
---|---|---|
20080287840 | NEUROLOGICAL MOTOR THERAPY SUIT - A neurological motor therapy suit includes a vest which is snugly, but removably, secured around the shoulders and chest of a patient. The vest completely encircles a portion of the upper torso of the patient and is constructed of a substantially non-elastic material. A pant garment is detachably secured to the patient so that the pant garment extends around both the hips of the patient as well as the upper portion of each thigh. The pant garment is also constructed of a substantially non-elastic material. A plurality of the elastic bands extend between and interconnect the vest and the pant garment. An elbow support is removably secured to the patient's elbow while a hand support is removably secured to the patient's hand. Both the elbow support and hand support include a plurality of hooks so that elastic bands detachably secure the hooks on the elbow support and hand support together as well as between the vest and the elbow support. | 11-20-2008 |
Izabela Lacka, Bytow PL
Patent application number | Description | Published |
---|---|---|
20150045316 | SEMISYNTHETIC DERIVATIVES OF NYSTATIN A1 - The invention provides semisynthetic derivatives of Nystatin A | 02-12-2015 |
Izabela Orlac, Breteil FR
Patent application number | Description | Published |
---|---|---|
20140282702 | METHOD AND APPARATUS FOR PROVIDING INFORMATION FOR A MULTIMEDIA CONTENT FILM - A method and an apparatus for providing information for a multimedia content item from a catalog of multimedia content items to a user with the capability of displaying intra-content and inter-content information are described. A sequence of concepts is generated for the multimedia content item using a concept graph and metadata associated to the multimedia content item. An enhanced sequence of concepts for the multimedia content item using the sequence of concepts and an enhanced concept graph. The enhanced sequence of concepts is then displayed to a user. | 09-18-2014 |
Izabela Sabala, Skierniewice PL
Patent application number | Description | Published |
---|---|---|
20140044698 | METHOD OF PEPTIDE HYDROLYSIS, PEPTIDASE, THE COMPOSITION FOR USE AS A BACTERIOSTATIC AND BACTERICIDAL AGENT, A KIT AND THE USES OF THE ACTIVE FORM OF LYTM FROM S. AUREUS OR DERIVATIVES THEREOF - The invention relates to new method of peptide hydrolysis, in particular of the cell walls of Gram-positive bacteria, wherein the active form of LytM or derivative thereof is contacted with a peptide substrate, preferably with the cell walls of Gram-positive bacteria, in an aqueous environment of conductivity lower than 10 mS/cm. The invention also relates to composition comprising active form of LytM or derivative thereof and new uses of active form of LytM or derivative thereof. | 02-13-2014 |
Izabela Sibilska, Warsaw PL
Patent application number | Description | Published |
---|---|---|
20110082121 | 1-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses - This invention discloses 1-desoxy-2-methylene-19-nor-vitamin D analogs, and specifically (20S)-25-hydroxy-1-desoxy-2-methylene-19-nor-vitamin D | 04-07-2011 |
20120157418 | 2-Methylene-19-Nor-Vitamin D Analogs and Their Uses - This invention discloses 2-methylene-19-nor-vitamin D analogs, and specifically (20S)-25-hydroxy-2-methylene-19-nor-vitamin D | 06-21-2012 |
20120322775 | 3-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses - This invention discloses 3-desoxy-2-methylene-19-nor-vitamin D analogs, and specifically (20S)-3-desoxy-2-methylene-1α,25-dihydroxy-19-nor-vitamin D | 12-20-2012 |
20130102567 | 3-Desoxy-2-Methylene-Vitamin D Analogs and Their Uses - This invention discloses 3-desoxy-2-methylene-vitamin D analogs, and specifically (20S)-3-desoxy-1α,25-dihydroxy-2-methylene-vitamin D | 04-25-2013 |
20130102573 | 2-METHYLENE-VITAMIN D ANALOGS AND THEIR USES - This invention discloses 2-methylene-vitamin D analogs, and specifically (20S)-25-hydroxy-2-methylene-vitamin D | 04-25-2013 |
20130102574 | 2-METHYLENE-VITAMIN D ANALOGS AND THEIR USES - This invention discloses 2-methylene-vitamin D analogs, and specifically (20S)-1α,25-dihydroxy-2-methylene-vitamin D | 04-25-2013 |
Izabela Struzynska-Piron, Mortsel BE
Patent application number | Description | Published |
---|---|---|
20150291843 | SOLVENT RESISTANT POLYMERIC MEMBRANES - A radiation curable composition for preparing a polymeric membrane includes a) a membrane polymer selected from the group consisting of a polysulfone (PSU), a polyether sulfone (PES), a polyether etherketone (PEEK), a polyvinylchloride (PVC), a polyacrylonitrile (PAN), a polyvinylidene fluoride (PVDF), a polyimide (PI), a polyamide (PA) and copolymers thereof; b) a hydrophobic monomer or oligomer having at least two free radical polymerizable groups independently selected from the group consisting of an acrylate group, a methacrylate group, an acrylamide group, a methacrylamide group, a styrene group, a vinyl ether group, a vinyl ester group, a maleate group, a fumarate group, an itaconate group, and a maleimide group; and c) an organic solvent for the membrane polymer and the hydrophobic monomer. A polymeric membrane and a method for manufacturing the membrane are also disclosed. | 10-15-2015 |
Izabela Tworowska, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20090087377 | COMPOSITIONS FOR TARGETED IMAGING AND THERAPY - The present invention relates to the field of radiochemistry, nuclear imaging, radionuclide therapy and chemical synthesis. More particularly, it concerns a strategy for radiolabeling target ligands. It further concerns methods of using those radiolabeled ligands for imaging, radionuclide therapy and tissue-specific disease imaging. | 04-02-2009 |
20100316566 | RADIOLABELED HEDGEHOG DERIVATIVES FOR IMAGING AND THERAPY - The present invention concerns methods and compositions related to a chelator and a HHRT ligand. In specific embodiments of the invention the chelator is conjugated to the HHRT ligand. In another specific embodiment of the invention, the chelator is chelated to a metal. In a particular embodiment of the invention, there is a metal species that is chelated to a chelator, which is then directly or indirectly conjugated to a HHRT ligand. In some embodiments, the composition further comprises a therapeutic agent. In particular cases, the compositions are employed for cancer diagnosis and/or therapy. | 12-16-2010 |
Izabela Ziuzia, Bydgoszcz PL
Patent application number | Description | Published |
---|---|---|
20130317102 | Novel Esters of (Acyloxymethyl)Acrylamide, a Pharmaceutical Composition Containing Them, and Their use as Inhibitors of the Thioredoxin - Thioredoxin Reductase System - The subject of the present invention are novel esters of (acyloxymethyl)acrylamide, a pharmaceutical composition containing them and their use in the production of drugs for the prophylaxis or treatment of oncogenic diseases and diseases connected with increased cell proliferation. | 11-28-2013 |